Swedish Orphan Biovitrum
388.60 SEK
-1.72 %
Less than 1K followers
SOBI
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-1.72 %
+15.31 %
+16.77 %
+13.96 %
+41.31 %
+23.13 %
+69.23 %
+188.23 %
+714.36 %
Swedish Orphan Biovitrum operates in the pharmaceutical industry and focuses on the development and distribution of medicines for rare diseases. The company's products are aimed at healthcare institutions and patients with specific medical needs. The business is global with a main presence in Europe, North America and Asia. Swedish Orphan Biovitrum was founded in 1939 and is headquartered in Stockholm, Sweden.
Read moreMarket cap
138.89B SEK
Turnover
126.75M SEK
Revenue
28.24B
EBIT %
3.07 %
P/E
279.57
Dividend yield-%
-
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
28/4
2026
Interim report Q1'26
6/5
2026
General meeting '26
16/7
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
Swedish Orphan Biovitrum AB: Sobis kapitalmarknadsdag 2026: Bringing brillant ideas to life - med ambitionen att nå 55 miljarder kronor till 2030 inleder vi nästa kapitel
Swedish Orphan Biovitrum AB: Sobi publicerar delårsrapport för fjärde kvartalet och bokslutskommuniké för 2025: Året avslutas med betydande tillväxt och strategiska framsteg
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools